---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-019961"
form_type: "8-K"
ticker: "AURX"
cik: "0001091596"
company_name: "Nuo Therapeutics, Inc."
filed_at: "2024-06-11T23:59:59+00:00"
generated_at: "2026-06-01T04:58:35.385249+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nuo Therapeutics dismisses auditor Marcum, engages MaloneBailey; cites material weaknesses

## Summary
- Effective June 7, 2024, dismissed Marcum LLP as independent auditor; engaged MaloneBailey, LLP for FY 2024.
- Marcum's reports for FY2023 and FY2022 included going-concern explanatory paragraphs.
- Identified material weaknesses: insufficient accounting staff and lack of effective internal control over financial reporting.
- No disagreements with Marcum on accounting principles or audit scope prior to dismissal.
- Marcum's letter to SEC agreeing with disclosures filed as Exhibit 16.1.

## SEC filing metadata
- accession: 0001437749-24-019961
- form_type: 8-K
- ticker: AURX
- cik: 0001091596
- company_name: Nuo Therapeutics, Inc.
- filed_at: 2024-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1091596/000143774924019961/0001437749-24-019961-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1091596/000143774924019961/aurx20240606_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-019961
- JSON: https://secwatch.observer/filing/0001437749-24-019961.json
- Plain text: https://secwatch.observer/filing/0001437749-24-019961.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.